Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women

American Journal of Epidemiology

Volumn 163, Issue 9, 2006, Pages 838-848

  Lindsay, Lisa ^a   Jackson, Lisa A ^b,c   Savitz, David A ^a   Weber, David J ^a,d,e   Koch, Gary G ^a   Kong, Lan ^f   Guess, Harry A ^g  

^a IL   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g NONE

Author keywords

Cohort studies; Immunization; Influenza, human; Postpartum period; Pregnancy; Regression analysis; Respiratory tract infections; Sentinel surveillance

Indexed keywords

COHORT ANALYSIS; HEALTH AND DISEASE; HEALTH RISK; IMMUNITY; INFLUENZA; PREGNANCY; REGRESSION ANALYSIS; RESPIRATION; WOMENS HEALTH;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ACTIVITY; FEMALE; FLU LIKE SYNDROME; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PARAINFLUENZA VIRUS; PREGNANCY; PUERPERIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK ASSESSMENT; VIRUS ISOLATION;

ACUTE DISEASE; FEMALE; HUMANS; INCIDENCE; INFLUENZA, HUMAN; ODDS RATIO; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VACCINATION; WASHINGTON;

NORTH AMERICA; UNITED STATES; WASHINGTON [UNITED STATES];

ADENOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS;

EID: 33646379624     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj095     Document Type: Article

References (62)

1. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54(RR-8):1-40.
2. Serfling RE, Sherman IL, Houseworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960, and 1963. Am J Epidemiol 1967;86:433-41.
3. Freeman D, Barno A. Death from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959;78:1172-5.
4. Greenberg M, Jacobziner H, Pakter J, et al. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol 1958;76:897-902.
5. Harris J. Influenza occurring in pregnant women. JAMA 1919;14:978-80.
6. Kort BA, Cefalo RC, Baker VV. Fatal influenza A pneumonia in pregnancy. Am J Perinatol 1986;3:179-82.
7. McKinney WP, Volkert P, Kaufman J. Fatal swine influenza pneumonia during late pregnancy. Arch Intern Med 1990;150:213-15.
8. Berkowitz K, LaSala A. Risk factors associated with the increasing prevalence of pneumonia during pregnancy. Am J Obstet Gynecol 1990;163:981-5.
9. Hopwood H. Pneumonia in pregnancy. Obstet Gynecol 1965;25:875-9.
10. Jewett JF. Influenza pneumonia at term. N Engl J Med 1974;291:256-7.
11. Madinger NE, Greenspoon JS, Ellrodt AG. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol 1989;161:657-62.
12. Leontic EA. Respiratory disease in pregnancy. Med Clin North Am 1977;61:111-28.
13. Rodrigues J, Niederman MS. Pneumonia complicating pregnancy. Clin Chest Med 1992;13:679-91.
14. Taina E, Hanninen P, Gronroos M. Viral infections in pregnancy. Acta Obstet Gynecol Scand 1985;64:167-73.
15. Ie S, Rubio ER, Alper B, et al. Respiratory complication of pregnancy. Obstet Gynecol Surv 2002;57:39-46.
16. Lederman MM. Cell-mediated immunity and pregnancy. Chest 1984;86(suppl):6S-9S.
17. Mullooly JP, Barker WH, Nolan TF Jr. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986;101:205-11.
18. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148:1094-102.
19. ACOG Committee on Obstetric Practice. ACOG committee opinion number 305, November 2004. Influenza vaccination and treatment during pregnancy. Obstet Gynecol 2004;104:1125-6.
20. Centers for Disease Control and Prevention. Influenza vaccination among adults and children during the 2004-05 influenza season: Behavioral Risk Factor Surveillance System (BRFSS) Summary for data collected January 2-22, 2005. Atlanta, GA: Centers for Disease Control and Prevention, 2005.
21. Ahmed F, Singleton JA, Franks AL. Clinical practice. Influenza vaccination for healthy young adults. N Engl J Med 2001;345:1543-7.
22. Neuzil KM, Griffin MR, Schaffner W. Influenza vaccine: issues and opportunities. Infect Dis Clin North Am 2001;15:123-41, ix.
23. Schrag SJ, Fiore AE, Gonik B, et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol 2003;101:704-10.
24. Tuyishime JD, DeWals P, Moutquin JM, et al. Influenza-like illness during pregnancy: results from a study in the eastern townships, Province of Quebec. J Obstet Gynaecol Can 2003;25:1020-5.
25. Silverman NS, Greif A. Influenza vaccination during pregnancy. Patients' and physicians' attitudes. J Reprod Med 2001;46:989-94.
26. Centers for Disease Control and Prevention. Interim estimates of populations targeted for influenza vaccination from 2003 National Health Interview Survey data and estimates for 2004 based on influenza vaccine shortage priority groups. Atlanta, GA: Centers for Disease Control and Prevention, 2005.
27. ICD-9-CM. International classification of diseases, Ninth Revision, Clinical Modification. 6th ed. Vols 1, 2, and 3. Los Angeles, CA: Practice Management Information Corporation, 2000.
28. American Medical Association. Current procedural terminology. CPT 2001. Standard ed. Chicago, IL: American Medical Association, 2000.
29. Mullooly J, Drew L, DeStefano F, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. Am J Epidemiol 1999;149:186-94.
30. Pearson D, Jackson LA, Winkler B, et al. Use of an automated pharmacy system and patient registries to recruit HMO enrollees for an influenza campaign. Eff Clin Pract 1999;2: 17-22.
31. Davies GM, Koch GG, Beck J. Statistical strategies for event rate comparisons in dental studies. J Biopharm Stat 1997;7:625-34.
32. Lavange LM, Keyes LL, Koch GG, et al. Application of sample survey methods for modeling ratios to incidence densities. Stat Med 1994;13:343-55.
33. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
34. Stokes ME, Davis CS, Koch GG. Generalized estimating equations. In: Categorical data analysis using the SAS system. 2nd ed. Cary, NC: SAS Institute, Inc, 2000:471-549.
35. Hertz-Picciotto I, Smith AH, Holtzman D, et al. Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology 1992;3:23-31.
36. Black SB, Shinefield HR, France EK, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004;21:333-9.
37. Tennessee Department of Human Services. Medicaid: Medicaid coverage to those that are medically needy. Nashville, TN: Tennessee Department of Human Services, 2003. (http:// www.state.tn.us/humanserv/medi.htm).
38. Carrat F, Tachet A, Rouzioux C, et al. Field investigation of influenza vaccine effectiveness on morbidity. Vaccine 1998;16:893-8.
39. Drews AL, Atmar RL, Glezen WP, et al. Dual respiratory virus infections. Clin Infect Dis 1997;25:1421-9.
40. Fleming DM, Chakraverty P, Sadler C, et al. Combined clinical and virological surveillance of influenza in winter of 1992 and 1993-4. BMJ 1995;311:290-1.
41. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44.
42. Monto AS, Ohmit SE, Margulies JR, et al. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. Am J Epidemiol 1995;141:502-6.
43. Sterner G, Grandien M, Enocksson E. Pregnant women with acute respiratory illness at term. Scand J Infect Dis Suppl 1990;71:19-26.
44. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988;127:353-64.
45. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112:798-811.
46. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
47. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153:2105-11.
48. Neuzil KM, Reed GW, Mitchel EF Jr, et al. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999;281:901-7.
49. Hartert TV, Neuzil KM, Shintani AK. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003;189:1705-12.
50. National Immunization Program, Centers for Disease Control and Prevention. Laboratory diagnostic procedures for influenza: diagnosis of influenza. Atlanta, GA: Centers for Disease Control and Prevention, 2003. (http://www.cdc.gov/ncidod/ diseases/flu/flu_dx_table.htm).
51. Munoz FM, Greisinger AJ, Wehmanen OA, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005;192:1098-106.
52. Deinard AS, Ogburn P Jr. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am J Obstet Gynecol 1981;140:240-5.
53. Glezen WP. Maternal vaccines. Prim Care 2001;28:791-806, vi-vii.
54. Heinonen OP, Shapiro S, Monson RR, et al. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229-35.
55. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979;140:141-6.
56. Yeager DP, Toy EC, Baker B 3rd. Influenza vaccination in pregnancy. Am J Perinatol 1999;16:283-6.
57. Englund J. Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine 2003;21:3460-4.
58. Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine 1998;16:1456-63.
59. Englund J, Mbawuike IN, Hammill H, et al. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993;168:647-56.
60. Mbawuike IN, Six HR, Cate TR, et al. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J Virol 1990;64:1370-4.
61. Puck JM, Glezen WP, Frank AL, et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980;142:844-9.
62. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J 1987;6:398-403.